4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-001525
Director bought 6,578 shares at $19.00 ($124,982)
- Director acquired 10,415,650 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cheng Isaac Director | 2022-01-06 | Conversion | +1,409,035 | 1,409,035 | I | ||
| Cheng Isaac Director | 2022-01-06 | Conversion | +6,410,964 | 7,819,999 | I | ||
| Cheng Isaac Director | 2022-01-06 | Conversion | +974,107 | 8,794,106 | I | ||
| Cheng Isaac Director | 2022-01-06 | Conversion | +1,621,544 | 10,415,650 | I | ||
| Cheng Isaac Director | 2022-01-06 | Purchase | +6,578 | $19.00 | $124,982 | 6,578 | D |
| Derivatives | |||||||
| Cheng Isaac Director | 2022-01-06 | Conversion · Series A Preferred Stock | −1,409,035 | 0 | I | ||
| Cheng Isaac Director | 2022-01-06 | Conversion · Series B Preferred Stock | −6,410,964 | 0 | I | ||
| Cheng Isaac Director | 2022-01-06 | Conversion · Series C-1 Preferred Stock | −974,107 | 0 | I | ||
| Cheng Isaac Director | 2022-01-06 | Conversion · Series C-2 Preferred Stock | −1,621,544 | 0 | I | ||
| Cheng Isaac Director | 2022-01-06 | Grant or award · Stock Option (Right to Buy) | +8,400 | 8,400 | D | ||
| Open-market purchases · 6,578 sh · avg $19.00 · $124,982 | |||||||
Loading xslF345X03/doc4.xml…